Similar articles

• Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.

  Voulgarelis M, Moutsopoulos HM. Voulgarelis M, et al. Rheum Dis Clin North Am. 2008 Nov;34(4):921-33, viii. doi: 10.1016/j.rdc.2008.08.006. Rheum Dis Clin North Am. 2008. PMID: 18984412 Review.
• Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.

  De Vita S, De Marchi G, Sacco S, Gremese E, Fabris M, Ferraccioli G. De Vita S, et al. Blood Cells Mol Dis. 2001 Jul-Aug;27(4):757-66. doi: 10.1006/bcmd.2001.0446. Blood Cells Mol Dis. 2001. PMID: 11778660 Review.
• Lymphoma in Sjögren's syndrome. From histopathology to molecular pathology.

  Jordan RC, Speight PM. Jordan RC, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):308-20. doi: 10.1016/s1079-2104(96)80331-3. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996. PMID: 8653465 Review.
• Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjögren's syndrome".

  Franco V, Iannitto E, Tripodo C, Florena AM. Franco V, et al. Clin Rheumatol. 2005 Apr;24(2):187; author reply 188. doi: 10.1007/s10067-004-0993-5. Clin Rheumatol. 2005. PMID: 15365879 No abstract available.
• Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.

  Pariente D, Anaya JM, Combe B, Jorgensen C, Emberger JM, Rossi JF, Sany J. Pariente D, et al. Eur J Med. 1992 Oct;1(6):337-42. Eur J Med. 1992. PMID: 1341461